23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Nordic
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement

How the Nobel discovery is used in drug development

Regulatory T cells keep the immune system in check, a discovery now awarded the 2025 Nobel Prize in Physiology or Medicine. Qiang Pan Hammarström explains how this finding is being applied in today’s drug development, and what challenges remain.
Advertisement

In 1995, Japanese researcher Shimon Sakaguchi made a key discovery in immunology. He identified a previously unknown class of immune cells that could protect the body against autoimmune diseases, cells that later became known as regulatory T cells, or Tregs.

Six years later, in 2001, American scientists Mary Brunkow and Fred Ramsdell published results explaining why a particular strain of mice was especially vulnerable to autoimmune disease. They found that the mice carried a mutation in a gene they named Foxp3. When the same mutation was later found in humans, it turned out to cause the severe condition known as IPEX.

Advertisement Advertisement
BREAKING
{{ article.headline }}
0.172|instance-web04